What This Document Is
This document is a pharmacology module focused on anti-inflammatory drugs and medications used for upper respiratory infections. It provides an overview of the inflammatory process, the distinction between inflammation and infection, and the mechanisms of action for various Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). It also briefly covers treatment approaches for common upper respiratory illnesses.
Why This Document Matters
This module is essential for students in Health-Illness Concepts Across the Lifespan I (NUR 1460C) at Florida State College at Jacksonville. Understanding pharmacology is foundational to nursing practice, and this module specifically addresses commonly encountered medications and conditions. It’s relevant when considering patient care related to pain management, fever reduction, and symptomatic relief of infections. This material builds a base understanding for more complex pharmacological concepts covered later in the course.
Common Limitations or Challenges
This module provides a foundational understanding but does *not* cover advanced pharmacology concepts like drug interactions in detail, or specific dosage calculations. It’s a starting point, and further study will be needed to apply this knowledge to clinical scenarios. It also doesn’t provide a comprehensive review of all possible upper respiratory pathogens.
What This Document Provides
This module includes:
* An explanation of the inflammatory process and its cardinal signs.
* A differentiation between inflammation and infection.
* Details on Cyclo-oxygenase (COX) enzymes and their role in inflammation.
* Information on first and second-generation NSAIDs, including specific examples like Aspirin, Ibuprofen, and Celebrex, and their associated risks and considerations.
* An overview of common upper respiratory infections (common cold, rhinitis, sinusitis, pharyngitis) and the rationale for symptomatic treatment.
* Information regarding the prevalence of osteoarthritis and NSAID use in the elderly population.
This preview *does not* include detailed dosage information, comprehensive drug interaction charts, or in-depth discussions of specific patient case studies. It also does not cover all medications used to treat upper respiratory infections, focusing instead on the rationale for symptomatic management.
